Skip to main content

Table 2 List of KDM genes described as relevant for PCa. For gene aliases, see Table 1

From: The emerging role of histone lysine demethylases in prostate cancer

GENE

ROLE IN PROSTATE CANCER

REF.

KDM1A

Oncogene, AR co-activator, associated with higher relapse risk

25-28

KDM2A

Putative tumor suppressor, reduced expression in PCa

41

KDM3A

Putative oncogene, overexpressed in PCa, AR co-activator

30, 33

KDM4A

Overexpressed in PCa

33

KDM4B

Overexpressed in PCa

33

KDM4C

Putative oncogene, overexpressed in CRPC, AR co-activator

30-32

KDM5B

Overexpressed in metastatic PCa, AR-co-activator

35

KDM5C

Putative oncogene, overexpressed in PCa, suppresses TGFB signalling

36

KDM6B

Putative oncogene, overexpressed in metastatic PCa

38

PHF8

Putative oncogene, overexpressed in PCa, mediates cell invasion

33